Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trialFan Yang, Jianxi Lu, Jintao Cheng et al.|Hepatology International|2023Cited by 31
273 Phase i study of LioCyx-M, autologous hepatitis B virus (HBV)-specific T cell receptor (TCR) T-cells, in recurrent HBV-related hepatocellular carcinoma (HCC) post-liver transplantationWenjie Chen, Qi Zhang, Jintao Cheng et al.|Regular and Young Investigator Award Abstracts|2020Cited by 4